News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synageva BioPharma (GEVA) Reports First Quarter 2013 Financial Results


5/8/2013 7:50:28 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, today reported first quarter 2013 financial results and provided other general business updates.

First Quarter 2013 Financial Results

For the quarter ended March 31, 2013, Synageva reported a net loss of $14.5 million compared to a net loss of $7.4 million for the corresponding quarter of the prior year.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES